Get 50% OFF This Summer!

Advertisement
AdvertisementAdvertisement
logo

Resonance Specialities

524218
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Resonance Specialities Share price and Fundamental Analysis

View All Details
View All Details
Resonance Specialities Limited (Formerly known Armour Polymers Limited) was incorporated in June, 1989 as a Private Limited Company in Maharashtra. The Company thereafter got converted into a Public Limited Company in March, 1990. The Company is manufacturing and marketing of Pyridine and Pyridine derivatives, Picoline, Cynopyridine and some bulk drugs.
Company Incorporation1989
ChairmanArchana Yadav
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
127.55
PE Ratio
17.86
Industry P/E
53.65
PEG Ratio
0.13
ROE
10.26%
ROCE
13.7%
ROA
8.71%
Total Debt (Cr)
3.31
Debt to Equity
0.05
Dividend Yield
0.91%
EPS
6.19
Book Value & P/B
52.3 x 2.11
Face Value
10
Outstanding Shares(Cr)
1.15
Current Ratio
7.85
EV to Sales
1.69

Included In

+More

Stock Returns

1 Week+37.73%
1 Month+36.63%
6 Months+7.31%
1 Year+6.84%
3 Years-17.24%
5 Years+155.56%

CAGR

1 Year CAGR

Revenue Growth

-2.94%

Net Profit Growth

-40.65%

Operating Profit Growth

-31.17%

Dividend Growth

-100%

Stock Returns CAGR

+6.84%
no_data

No Stocks

Smart Score

2.3
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 54.25%

FIIs : 0.03%

DIIs : 0.03%

Public : 45.70%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Resonance Specialities Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Resonance Specialities Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Resonance Specialities Limited (Formerly known Armour Polymers Limited) was incorporated in June, 1989 as a Private Limited Company in Maharashtra. The Company thereafter got converted into a Public Limited Company in March, 1990. The Company is manufacturing and marketing of Pyridine and Pyridine derivatives, Picoline, Cynopyridine and some bulk drugs.

The Company's plant is located in the Tarapur Industrial Zone near Mumbai , India. It has plants to manufacture Pyridines, Picolines, Lutidines, Collidines, Cyanopyridines and for various value added products. In Feb.'92, it came out with a public issue to part-finance a project to manufacture 324 tpa of picoline (alpha, beta and gamma) and 346 tpa of pyridine.

Pyridines and picolines are widely used in pharmaceuticals, chemicals, dyestuffs and agro chemicals. Pyridine is the raw material used to manufacture chloramphenicol and chlropheniramine maleate. It is used as a solvent in the manufacture of pharmaceuticals such as norfloxacin and sulphamethoxazole. It is also used as a solvent in the dyestuff industry, as a raw material in agro-chemicals and as a de-naturant in the alcohol industry. Beta picoline is used in the manufacture of niacin and niacinamide, which have wide applications in vitamin prepartions and are also used extensively as animal feed additives.

Gamma picoline is used in the manufacture of isonicotinic hydrazide and as an anti-TB drug. Alpha picoline is used in the manufacture of a wide variety of agro chemicals and 2-vinyl pyridine (used extensively in the rubber and tyre industries. The company also manufactures pyridine derivatives like cyano-pyridines.

The Company tripled its production capacities of Cyanopyridines. The upgradation of the Tarapur plant from 500 TPA to 1500 TPA is being done in close co-operation with Reilly Chemicals S.A. (Reilly) Belgium, a major shareholder in the Company.

During the year 2018-19, the Pilot Plant capacities was enhanced and a new fixed bed-fluidized and reactor was installed with latest automatic technology to monitor and record the reaction.

During 2020-21, projects including Scrubber addition to improve efficiencies; DG Capacity enhancement; Finished Goods Godown Extension; Power savings by Motor optimization and Ammonia Recovery Project were undertaken for enhancing the capacity.

Resonance Specialities Share Price

Resonance Specialities share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Resonance Specialities Market Cap

Market capitalization of Resonance Specialities indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Resonance Specialities is valued compared to its competitors.

Resonance Specialities PE Ratio

Resonance Specialities PE ratio helps investors understand what is the market value of each stock compared to Resonance Specialities 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Resonance Specialities PEG Ratio

The PEG ratio of Resonance Specialities evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Resonance Specialities ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Resonance Specialities generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Resonance Specialities ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Resonance Specialities in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Resonance Specialities Total Debt

Total debt of Resonance Specialities shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Resonance Specialities Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Resonance Specialities compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Resonance Specialities CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Resonance Specialities over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Resonance Specialities Technical Analysis

Technical analysis of Resonance Specialities helps investors get an insight into when they can enter or exit the stock. Key components of Resonance Specialities Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Resonance Specialities shares often struggle to rise above due to selling pressure.

Resonance Specialities Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Resonance Specialities ’s financial health and profitability.

Resonance Specialities Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Resonance Specialities Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Resonance Specialities Financials

The financials of Resonance Specialities provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Resonance Specialities Profit and Loss Statements

The profit and loss statement of Resonance Specialities highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Resonance Specialities .

Resonance Specialities Balance Sheet

The balance sheet presents a snapshot of Resonance Specialities ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Resonance Specialities Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App